Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/5837
Title: Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial.
Authors: Berenguera, A
Pujol-Ribera, E
Rodriguez-Blanco, T
Violan, C
Casajuana, M
de Kort, N
Trapero-Bertran, M
Keywords: Low back pain (LBP);Non-specific sub-acute LBP;Catalan;Primary healthcare centres;Sick leave;Multi disciplinary biopsychosocial educational group intervention (MBEGI)
Issue Date: 2011
Publisher: BioMed Central
Citation: BMC Musculoskeletal Disorders, 12:194, 2011
Abstract: Background: Low back pain (LBP), with high incidence and prevalence rate, is one of the most common reasons to consult the health system and is responsible for a significant amount of sick leave, leading to high health and social costs. The objective of the study is to assess the cost-effectiveness and cost-utility analysis of a multidisciplinary biopsychosocial educational group intervention (MBEGI) of non-specific sub-acute LBP in comparison with the usual care in the working population recruited in primary healthcare centres. Methods/design: The study design is a cost-effectiveness and cost-utility analysis of a MBEGI in comparison with the usual care of non-specific sub-acute LBP.Measures on effectiveness and costs of both interventions will be obtained from a cluster randomised controlled clinical trial carried out in 38 Catalan primary health care centres, enrolling 932 patients between 18 and 65 years old with a diagnosis of non-specific sub-acute LBP. Effectiveness measures are: pharmaceutical treatments, work sick leave (% and duration in days), Roland Morris disability, McGill pain intensity, Fear Avoidance Beliefs (FAB) and Golberg Questionnaires. Utility measures will be calculated from the SF-12. The analysis will be performed from a social perspective. The temporal horizon is at 3 months (change to chronic LBP) and 12 months (evaluate the outcomes at long term. Assessment of outcomes will be blinded and will follow the intention-to-treat principle. Discussion: We hope to demonstrate the cost-effectiveness and cost-utility of MBEGI, see an improvement in the patients' quality of life, achieve a reduction in the duration of episodes and the chronicity of non-specific low back pain, and be able to report a decrease in the social costs. If the intervention is cost-effectiveness and cost-utility, it could be applied to Primary Health Care Centres. Trial registration: ISRCTN: ISRCTN58719694
Description: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
URI: http://www.biomedcentral.com/1471-2474/12/194
http://bura.brunel.ac.uk/handle/2438/5837
DOI: http://dx.doi.org/10.1186/1471-2474-12-194
ISSN: 1471-2474
Appears in Collections:Publications
Community Health and Public Health
Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdf174.2 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.